Current Value of Holding

$0

Shares

0

% of Portfolio

0.00%

Average Buy Price

$22.6

Avg closing price
Price range

2 Joel Greenblatt Immunovant Trades

Joel Greenblatt started to build up the position in Immunovant in Q3 2023. Since then they sold 5.53 Thousand shares. The investor sold all their shares in Q4 2023 and doesn't own any shares in Immunovant anymore.

Avg closing price
Price range
Sold -5.53 Thousand shares Q4 2023
Avg closing price $36.80
Price range $31.31 - $44.19
New holding (+5.53 Thousand shares) Q3 2023
Avg closing price $22.60
Price range $18.55 - $39.96

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!